# A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis

> **NCT07185282** · PHASE3 · COMPLETED · sponsor: **Minghui Pharmaceutical (Hangzhou) Ltd** · enrollment: 375 (actual)

## Conditions studied

- Atopic Dermatitis (AD)

## Interventions

- **DRUG:** MH004 Ointment
- **DRUG:** Vehicle Ointment

## Key facts

- **NCT ID:** NCT07185282
- **Lead sponsor:** Minghui Pharmaceutical (Hangzhou) Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-10
- **Primary completion:** 2024-12-13
- **Final completion:** 2025-08-15
- **Target enrollment:** 375 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07185282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07185282, "A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07185282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*